Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.
about
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.Biologically based treatment approaches to the patient with resistant perinatal depression.Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression.Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortex.
P2860
Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@ast
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@en
type
label
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@ast
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@en
prefLabel
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@ast
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@en
P2860
P1476
Fluoxetine and olanzapine comb ...... w of efficacy and safety data.
@en
P2093
Richard C Shelton
William Victor Bobo
P2860
P304
P356
10.1517/14656560903130609
P407
P577
2009-09-01T00:00:00Z